ZM008

Zumutor Biologics Inc. · Phase 1 active Biologic

At a glance

Generic name	ZM008
Also known as	Antibody
Sponsor	Zumutor Biologics Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ZM008 CI brief — competitive landscape report
ZM008 updates RSS · CI watch RSS
Zumutor Biologics Inc. portfolio CI